Gefitinib (250 mg)

admin — Wed, 18 Feb 2026 10:55:05 +0000

Overview: Afzanna 30 mg Afatinib Tablets contain Afatinib (30 mg) and are prescribed as an oral targeted anticancer medicine for the treatment of EGFR-mutated non-small cell lung cancer (NSCLC) by blocking specific signaling pathways that promote cancer cell growth. Key Benefits: – Targets EGFR signaling to slow tumor progression in NSCLC – Oral dosing for outpatient convenience – Used in patients with confirmed EGFR mutations Composition: Afatinib (30 mg) How It Works: Afatinib is an irreversible tyrosine kinase inhibitor that blocks EGFR and related growth factor receptors, reducing cancer cell proliferation and tumor growth in susceptible NSCLC cases. Usage Instructions: – Take exactly as directed by your oncologist – Swallow the tablet whole with water, with or without food – Do not crush or chew the tablet Side Effects: – Diarrhea, rash, acne-like skin reactions – Nausea, vomiting, mouth sores – Fatigue, decreased appetite Precautions: – Not recommended during pregnancy or breastfeeding — discuss with healthcare provider before use – Monitor liver function tests during treatment – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

afatinib tablet – Globalstar International

Gefitinib (250 mg)